I’m interested to see efficacy results that star
Post# of 15624
(Total Views: 373)
Posted On: 01/30/2019 9:23:08 PM
I’m interested to see efficacy results that start this quarter on the sublingual tablet against chronic pain syndrome. Also, I am excited how it will compare with GWPH ‘s drug if their amendment is granted. Zevi is also pushing MM along. So many reasons to keep a core amount of shares. I will say I’m not enthused about efficacy on the cream starting in Q3.
I’m hopeful since the tablet is 100 percent OWCP and managements that it’s studies move along at a much more rapid pace unlike the cream that is partially owned by Sheba. Let’s see if the tablet safety study timeline follows Closer to their predictions.
I’m hopeful since the tablet is 100 percent OWCP and managements that it’s studies move along at a much more rapid pace unlike the cream that is partially owned by Sheba. Let’s see if the tablet safety study timeline follows Closer to their predictions.
(1)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼